OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
December 11, 2015
Grand River Aseptic Manufacturing expands disposable technology capabilities at aseptic facility.
December 10, 2015
Ajinomoto Althea expands biological drug product manufacturing operations to include ADCs.
December 08, 2015
Ropack Inc. adds R&D, formulation, lab analysis, and manufacturing capabilities in Long Island, NY.
December 04, 2015
Paragon Bioservices entered into a contract with the International Aids Vaccine Initiative for the process and analytical development and cGMP manufacturing of an HIV vaccine candidate.
December 02, 2015
CMO industry consolidation may be frustrated by a dearth of attractive assets.
November 30, 2015
As 3-D screening and lab automation improve lead optimization, open collaborative models are breaking down long-established walls. Will the industry redefine the way it handles R&D?
November 26, 2015
Ash Stevens has received FDA’s approval to manufacture Takeda’s multiple myeloma drug, ixazomib, at its facility in Riverview, Michigan.
November 23, 2015
The University of Sheffield has appointed Cobra Biologics to advance novel fusion protein technology into Phase 1 clinical trials.
November 20, 2015
Expansions at Catalent’s Kansas City, MO, and Madison, WI facilities made in response to industry demand.
November 17, 2015
Operations at Catalent’s Beinheim, France, softgel facility were suspended following suspected deliberate action to misplace capsules.